Literature DB >> 2675834

Synthetic non-peptide inhibitors of HIV protease.

J J Blumenstein1, T D Copeland, S Oroszlan, C J Michejda.   

Abstract

We have studied the inhibition of HIV protease by the antifungal antibiotic cerulenin, as well as by several related synthetic, structurally simpler analogs. The effect of these compounds on HIV protease was conveniently studied by monitoring the cleavage of an authentic single peptide bond in a synthetic nonapeptide corresponding to a natural cleavage site in HIV-1 gag precursor polyprotein. The relative inhibitory effects of these compounds have afforded an insight into the structural characteristics which impart antiprotease activity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2675834     DOI: 10.1016/0006-291x(89)92318-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease.

Authors:  R L DesJarlais; G L Seibel; I D Kuntz; P S Furth; J C Alvarez; P R Ortiz de Montellano; D L DeCamp; L M Babé; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

2.  beta-Galactosidase containing a human immunodeficiency virus protease cleavage site is cleaved and inactivated by human immunodeficiency virus protease.

Authors:  E Z Baum; G A Bebernitz; Y Gluzman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

3.  CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity.

Authors:  E Alteri; G Bold; R Cozens; A Faessler; T Klimkait; M Lang; J Lazdins; B Poncioni; J L Roesel; P Schneider
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

Review 4.  HIV Protease: Historical Perspective and Current Research.

Authors:  Irene T Weber; Yuan-Fang Wang; Robert W Harrison
Journal:  Viruses       Date:  2021-05-06       Impact factor: 5.048

5.  Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings.

Authors:  Mitzie-Ann Davis; Joe R Delaney; Chandni B Patel; Ryan Storgard; Dwayne G Stupack
Journal:  Drug Des Devel Ther       Date:  2016-06-02       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.